Impact of sperm DNA fragmentation in couples with unexplained recurrent pregnancy loss: A cross-sectional study.
DNA fragmentation index (DFI)
sperm DNA fragmentation (SDF)
sperm chromatin dispersion test (SCD)
unexplained recurrent pregnancy loss (unexplained RPL)
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
03 Aug 2024
03 Aug 2024
Historique:
received:
20
02
2024
accepted:
17
07
2024
medline:
3
8
2024
pubmed:
3
8
2024
entrez:
3
8
2024
Statut:
aheadofprint
Résumé
Recurrent pregnancy loss (RPL) has a multifactorial etiology, with a majority of cases remaining unexplained. To account for these unexplained cases, possible male factors are being explored. Conventional semen analysis lacks a qualitative assessment of sperms and information regarding sperm DNA integrity. Sperm DNA fragmentation (SDF) has diagnostic value in unexplained RPL, and it may account for a number of unexplained cases. Hence, we planned a study to explore and evaluate the impact of sperm DNA fragmentation in couples with unexplained recurrent pregnancy losses. Analytical cross-sectional study was conducted at a tertiary-level referral facility in India between August 2021 and July 2023. Participants (n = 70) were divided into two groups-male partners of couples with unexplained RPL (following spontaneous conceptions) (n = 35) and men with at least one previous live birth (spontaneous or following fertility treatments for female factor infertility such as ovulation induction or intrauterine insemination) as controls (n = 35). Neither of the two groups of couples recruited for this study had undergone ART as fertility treatment. Primary outcome assessed was mean DNA fragmentation index (DFI). Secondary outcomes included differences in semen parameters such as sperm concentration, progressive sperm motility and morphology, proportion of men with high (≥30%) and low DFI in the two groups, and the association between various semen parameters and DFI. Univariate logistic regression revealed that sperm DNA fragmentation was higher in men with unexplained RPL (30.0; IQR (interquartile range) 19.0, 46.0) as compared to controls (22.0; IQR 14.0, 30.0) although it was not statistically significant (OR, odds ratio, 1.02; 95% CI 1.0-1.1, p = 0.08). A higher proportion of men with unexplained RPL had DFI ≥30% compared to controls (54.2% vs. 25.7%; OR 3.43 (95% CI 1.2-9.4); p = 0.02). No statistically significant differences were observed in semen volume, sperm concentration, progressive motility, and morphology between the two groups. Sperm DNA fragmentation index also showed a weak but significant inverse relationship with sperm morphology (r = -0.336, p = 0.004). The current study did not show any significant difference in the mean sperm DNA fragmentation levels in male partners of couples with unexplained RPL compared to controls. However, a higher proportion of men with DFI ≥30% were observed in unexplained RPL population when compared to controls.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Japan Society of Obstetrics and Gynecology.
Références
ESHRE guideline: recurrent pregnancy loss: an update in 2022† | Human Reproduction Open | Oxford Academic [Internet]. [cited 2023 Sep 3]. Available from: https://academic.oup.com/hropen/article/2023/1/hoad002/7068067
Larsen EC, Christiansen OB, Kolte AM, Macklon N. New insights into mechanisms behind miscarriage. BMC Med. 2013 Jun 26;11(1):154.
Du Fossé NA, Van Der Hoorn MLP, De Koning R, Mulders AGMGJ, Van Lith JMM, Le Cessie S, et al. Toward more accurate prediction of future pregnancy outcome in couples with unexplained recurrent pregnancy loss: taking both partners into account. Fertil Steril. 2022 Jan;117(1):144–152.
Miller D, Pavitt S, Sharma V, Forbes G, Hooper R, Bhattacharya S, et al. Physiological, hyaluronan‐selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two‐group, randomised trial. Lancet. 2019 Feb 2;393(10170):416–422.
Antioxidants for male subfertility—de Ligny, W—2022 | Cochrane Library [Internet]. [cited 2023 Aug 15]. Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007411.pub5/full
Giwercman A, Richthoff J, Hjøllund H, Bonde JP, Jepson K, Frohm B, et al. Correlation between sperm motility and sperm chromatin structure assay parameters. Fertil Steril. 2003 Dec 1;80(6):1404–1412.
Moskovtsev SI, Willis J, Azad A, Mullen JBM. Sperm Dna integrity: correlation with sperm plasma membrane integrity in semen evaluated for male infertility. Arch Androl. 2005 Jan 1;51(1):33–40.
Agarwal A, Majzoub A, Baskaran S, Panner Selvam MK, Cho CL, Henkel R, et al. Sperm DNA fragmentation: a new guideline for clinicians. World J Mens Health. 2020;38(4):412–471.
Agarwal A, Allamaneni SSR. The effect of sperm DNA damage on assisted reproduction outcomes. Minerva Ginecol. 2004;56(3):235–245.
Sbracia M, Cozza G, Grasso JA, Mastrone M, Scarpellini F. Semen parameters and sperm morphology in men in unexplained recurrent spontaneous abortion, before and during a 3 year follow‐up period. Hum Reprod. 1996 Jan 1;11(1):117–120.
Bhattacharya SM. Association of various sperm parameters with unexplained repeated early pregnancy loss—which is most important? Int Urol Nephrol. 2008 Jun;40(2):391–395.
Zhang L, Wang L, Zhang X, Xu G, Zhang W, Wang K, et al. Sperm chromatin integrity may predict future fertility for unexplained recurrent spontaneous abortion patients. Int J Androl. 2012;35(5):752–757.
Coughlan C, Clarke H, Cutting R, Saxton J, Waite S, Ledger W, et al. Sperm DNA fragmentation, recurrent implantation failure and recurrent miscarriage. Asian J Androl. 2015;17(4):681–685.
Venkatesh S, Singh A, Shamsi MB, Thilagavathi J, Kumar R, Mitra DK, et al. Clinical significance of sperm DNA damage threshold value in the assessment of male infertility. Reprod Sci. 2011 Oct;18(10):1005–1013.
Brahem S, Mehdi M, Landolsi H, Mougou S, Elghezal H, Saad A. Semen parameters and sperm DNA fragmentation as causes of recurrent pregnancy loss. Urology. 2011 Oct;78(4):792–796.
Bareh GM, Jacoby E, Binkley P, Schenken RS, Robinson RD. Sperm deoxyribonucleic acid fragmentation assessment in normozoospermic male partners of couples with unexplained recurrent pregnancy loss: a prospective study. Fertil Steril. 2016 Feb;105(2):329–336.e1.
Kumar K, Deka D, Singh A, Mitra DK, Vanitha BR, Dada R. Predictive value of DNA integrity analysis in idiopathic recurrent pregnancy loss following spontaneous conception. J Assist Reprod Genet. 2012 Sep;29(9):861–867.
Khadem N, Poorhoseyni A, Jalali M, Akbary A, Heydari ST. Sperm DNA fragmentation in couples with unexplained recurrent spontaneous abortions. Andrologia. 2014;46(2):126–130.
Zhu XB, Chen Q, Fan WM, Niu ZH, Xu BF, Zhang AJ. Sperm DNA fragmentation in Chinese couples with unexplained recurrent pregnancy loss. Asian J Androl. 2019 Jul 23;22(3):296–301.
Esquerré‐Lamare C, Walschaerts M, Chansel Debordeaux L, Moreau J, Bretelle F, Isus F, et al. Sperm aneuploidy and DNA fragmentation in unexplained recurrent pregnancy loss: a multicenter case‐control study. Basic Clin Androl. 2018 Dec;28(1):4.
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012 Nov;98(5):1103–1111.
Tomlinson M, Lewis S, Morroll D. Sperm quality and its relationship to natural and assisted conception: British fertility society guidelines for practice. Hum Fertil. 2013 Sep;16(3):175–193.
Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HWG, Behre HM, et al. World Health Organization reference values for human semen characteristics*‡. Hum Reprod Update. 2010 Jan 1;16(3):231–245.
Fernández JL, Muriel L, Goyanes V, Segrelles E, Gosálvez J, Enciso M, et al. Simple determination of human sperm DNA fragmentation with an improved sperm chromatin dispersion test. Fertil Steril. 2005 Oct 1;84(4):833–842.
Evenson DP, Larson KL, Jost LK. Sperm chromatin structure assay: its clinical use for detecting sperm DNA fragmentation in male infertility and comparisons with other techniques. J Androl. 2002;23(1):25–43.
Buck Louis GM, Sundaram R, Schisterman EF, Sweeney A, Lynch CD, Kim S, et al. Semen quality and time to pregnancy: the longitudinal investigation of fertility and the environment study. Fertil Steril. 2014 Feb 1;101(2):453–462.
Halim B, Lubis HP. The association between sperm DNA fragmentation and idiopathic early recurrent pregnancy loss. KnE Med. 2016 Oct;4:55–63.
Chohan KR, Griffin JT, Lafromboise M, De Jonge CJ, Carrell DT. Comparison of chromatin assays for DNA fragmentation evaluation in human sperm. J Androl. 2006;27(1):53–59.
Evenson DP, Jost LK, Marshall D, Zinaman MJ, Clegg E, Purvis K, et al. Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic. Hum Reprod. 1999 Apr 1;14(4):1039–1049.
Fernández JL, Muriel L, Rivero MT, Goyanes V, Vazquez R, Alvarez JG. The sperm chromatin dispersion test: a simple method for the determination of sperm DNA fragmentation. J Androl. 2003;24(1):59–66.